Paradoxically, this defect makes ovarian cancer cells more vulnerable to oncolytic viruses like HSV1Δγ34.5, which can replicate more effectively in STING-deficient cells, leading to cell lysis and tumor reduction. Here, STING1 is linked to neoplasm.